CRVS
Corvus Pharmaceuticals, Inc. · Healthcare
Orbimed Advisors LLC bought $4.5M of Corvus Pharmaceuticals, Inc.
Director and 10% owner
Bought$4,499,999
$3.50Price
1,285,714Shares
+19%Stake
What CRVS did for a copier
- $1,000 copied at Mon, Feb 22 open, $3.95
- $777
- S&P 500, same days
- +5.3%
Measured over 30 trading days, to the Apr 6 close.
Orbimed Advisors LLC's record
34 other buys with 3 months of prices since 2016: on average −11.7% against the S&P 500, and 12 of 34 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Feb 17. Filed Fri, Feb 19. Returns use the Feb 22 open and the Apr 6 close. Not investment advice.